New discovery being dubbed as a 'super antibody'

By Admin
A ‘super antibody which fights against all types of influenza A has been discovered by a team of Swiss and British researchers. The scientists ar...

A ‘super antibody’ which fights against all types of influenza A has been discovered by a team of Swiss and British researchers.

The scientists are now hopeful the finding could lead to the development of an emergency treatment for the virus and revolutionise flu vaccines.

In the current situation, flu vaccine makers have to adapt their jabs every year to make sure they are able to combat the seasonal flu strains.

However, the new development looks like it could act as a universal vaccine which has the ability to fight many types of the flu virus.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

After looking at 100,000 cell samples, the scientists were able to identify an antibody which effectively targeted the haemagglutinin protein which is found on the surface of all influenza A viruses.

Sir John Skehel, a Medical Research Council scientist who worked on the project, said in a media interview: “We've tried every subtype of influenza A and it interacts with them all.

“We eventually hope it can be used as a therapy by injecting the antibody to stop the infection.”

Meanwhile, the director of the Institute for Research in Biomedicine in Switzerland, Antonio Lanzavecchia, stated: “As the first and only antibody which targets all known subtypes of the influenza A virus, FI6 represents an important new treatment option.”

The findings of the experiments have been published in the Science Express journal. 

Share

Featured Articles

WHO Health Chatbot Built on 'Humanised' GenAI

World Health Organisation's GenAI digital health tool is built using ‘AI humanisation’ tech & designed to ease burden on health workers & educate on health

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

Hospitals

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance